Published • loading... • Updated
Cellectar Biosciences, Inc. (NASDAQ:CLRB) Stock Rated “Moderate Buy” by Sell-Side Brokerages
Summary by thecerbatgem.com
This story is only covered by news sources that have yet to be evaluated by the independent media monitoring agencies we use to assess the quality and reliability of news outlets on our platform. Learn more here.1 Articles
1 Articles
Cellectar Biosciences, Inc. (NASDAQ:CLRB) Stock Rated “Moderate Buy” by Sell-Side Brokerages
Cellectar Biosciences, Inc. (NASDAQ:CLRB – Get Free Report) has earned an average recommendation of “Moderate Buy” from the five research firms that are currently covering the stock, Marketbeat reports. One equities research analyst has rated the stock with a sell rating, three have given a buy rating and one has given a strong buy rating […]
Coverage Details
Total News Sources1
Leaning Left0Leaning Right0Center0Last UpdatedBias DistributionNo sources with tracked biases.
Bias Distribution
- There is no tracked Bias information for the sources covering this story.
Factuality
To view factuality data please Upgrade to Premium
